Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo
Year: 2012
Type: article
Abstract: Fragment-based design was used to guide derivatization of a lead series of β-lactamase inhibitors that had heretofore resisted optimization for in vivo activity. X-ray structures of fragments overlaid with the lead suggested new, unanticipated functionality and points of attachment. Synthesis of three derivatives improved affinity over 20-fold and improved efficacy in cell culture. Crystal structures were consistent with the fragment-based design, enabling further optimization to a K(i) of 50 pM, a 500-fold improvement that required the synthesis of only six derivatives. One of these, compound 5, was tested in mice. Whereas cefotaxime alone failed to cure mice infected with β-lactamase-expressing Escherichia coli, 65% were cleared of infection when treated with a cefotaxime:5 combination. Fragment complexes offer a path around design hurdles, even for advanced molecules; the series described here may provide leads to overcome β-lactamase-based resistance, a key clinical challenge.
Institutions: University of California, San Francisco, University of Modena and Reggio Emilia, Inserm, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Microbe, Intestine, Inflammation and Host Susceptibility, Institut National de la Recherche Agronomique, Université de Clermont I, Centre Hospitalier Universitaire de Clermont-Ferrand
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2094208194
